Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution

Published:2022-07 Issue:5 Volume:22 Page:e680-e684
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Arole Vidya,Shafi Saba,Challa Bindu,Parwani Anil V.,Tozbikian Gary,Li Zaibo^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade;Le;Science,2017

2. PD-1 blockade in tumors with mismatch-repair deficiency;Le;N Engl J Med,2015

3. Programmed death ligand 1 expression among 700 consecutive endometrial cancers: strong association with mismatch repair protein deficiency;Li;Int J Gynecol Cancer,2018

4. Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium;Willis;Mod Pathol,2017

5. Clinical impact of programmed cell death ligand 1 expression in colorectal cancer;Droeser;Eur J Cancer,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP